LaserAway, a US medspa and aesthetic dermatology operator backed by Ares Management and Seidler Equity Partners, is exploring a potential sale that could value the business at more than $2bn, according to a report by Reuters citing unnamed people familiar with the situation.
The Los Angeles-based company has engaged investment bank Harris Williams to advise on a process that is still in its early stages, the sources said. The discussions remain confidential and no final decision has been made regarding a transaction.
Ares, LaserAway, Seidler Equity Partners and Harris Williams reportedly declined to comment when contacted.
Founded in 2006 by Dr Roy Winston alongside brothers Scott, Todd and Brock Heckmann, LaserAway has grown into a nationwide provider of non-surgical cosmetic treatments. Its offerings include laser hair removal and tattoo removal, skin rejuvenation services, and injectable treatments such as Botox. Pricing for laser hair removal typically ranges from around $99 to $649 per session, with additional bundled packages and financing options available to customers.
The company is understood to generate approximately $150m in annual EBITDA, reflecting strong margins supported by repeat consumer demand in aesthetic procedures.
Private equity firms have shown sustained interest in the medspa and aesthetics sector in recent years, attracted by recurring revenue models and resilient consumer spending on elective treatments. Recent activity in the space includes General Atlantic’s take-private of European Wax Center, Stride Consumer Partners’ investment in Peachy, Leonard Green & Partners’ ownership of Milan Laser, and KKR’s backing of SkinSpirit.
Ares acquired a significant minority stake in LaserAway in 2021, when the company operated 74 clinics. Since then, the business has expanded rapidly and now operates 219 locations across the United States, positioning itself as one of the largest aesthetics and dermatology-focused chains in the country.
The company recently marked the opening of its 219th clinic, framing the milestone as part of its 20th anniversary year and highlighting its long-term expansion without any clinic closures, an achievement it described as unusual within both the retail and medical aesthetics sectors.
